Evidence map›Paper›PMID 37709773›Full record

ReviewSignal transduction and targeted therapy2023

Endoplasmic reticulum stress: molecular mechanism and therapeutic targets.

Xingyi Chen, Chaoran Shi, Meihui He, Siqi Xiong, Xiaobo Xia

Open access · goldAbstract readReview
In one paragraph

Review in Signal transduction and targeted therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 592 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
592citing papers in PubMed, 2 pooled it
173.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

592 citing papers in PubMed, 2 syntheses or guidelines pooled it, 816 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Sulfur Vacancy-Enriched CuAngewandte Chemie (International ed. in English) · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Article

532 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Xingyi ChenEye Center of Xiangya Hospital, Central South University, 410008, Changsha, Hunan, China.
Chaoran ShiNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Meihui HeEye Center of Xiangya Hospital, Central South University, 410008, Changsha, Hunan, China.
Siqi XiongEye Center of Xiangya Hospital, Central South University, 410008, Changsha, Hunan, China. petersage1221@126.com.
Xiaobo XiaEye Center of Xiangya Hospital, Central South University, 410008, Changsha, Hunan, China. xbxia21@csu.edu.cn.ORCID http://orcid.org/0000-0003-1720-7860
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endoplasmic reticulum (ER) functions as a quality-control organelle for protein homeostasis, or "proteostasis". The protein quality control systems involve ER-associated degradation, protein chaperons, and autophagy. ER stress is activated when proteostasis is broken with an accumulation of misfolded and unfolded proteins in the ER. ER stress activates an adaptive unfolded protein response to restore proteostasis by initiating protein kinase R-like ER kinase, activating transcription factor 6, and inositol requiring enzyme 1. ER stress is multifaceted, and acts on aspects at the epigenetic level, including transcription and protein processing. Accumulated data indicates its key role in protein homeostasis and other diverse functions involved in various ocular diseases, such as glaucoma, diabetic retinopathy, age-related macular degeneration, retinitis pigmentosa, achromatopsia, cataracts, ocular tumors, ocular surface diseases, and myopia. This review summarizes the molecular mechanisms underlying the aforementioned ocular diseases from an ER stress perspective. Drugs (chemicals, neurotrophic factors, and nanoparticles), gene therapy, and stem cell therapy are used to treat ocular diseases by alleviating ER stress. We delineate the advancement of therapy targeting ER stress to provide new treatment strategies for ocular diseases.

Indexed as

Color Vision DefectsEndoplasmic Reticulum StressAutophagyEpigenomicsHumansUnfolded Protein Response

Identifiers

PMID37709773
PMCPMC10502142
OpenAlexW4386728322

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.